ella

About Ella Korets-Smith

This author has not yet filled in any details.
So far Ella Korets-Smith has created 13 blog entries.

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES CLOSING OF SECOND TRANCHE OF AN OVER-SUBSCRIBED NON-BROKERED PRIVATE PLACEMENT

2018-03-13T09:17:12+00:00

Vancouver, British Columbia / March 12, 2018 – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) is pleased to announce that, further to its news release of March 5, 2018 and, due to high demand, it has closed a second tranche of its over-subscribed private placement (the “Private Placement”) raising additional [...]

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES CLOSING OF SECOND TRANCHE OF AN OVER-SUBSCRIBED NON-BROKERED PRIVATE PLACEMENT 2018-03-13T09:17:12+00:00

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES INCREASE TO NON-BROKERED PRIVATE PLACEMENT

2018-03-08T09:07:26+00:00

Vancouver, British Columbia / March 7, 2018 – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) is pleased to announce that, further to its news releases of February 21, 2018 and March 5, 2018, it has increased the previously announced private placement of units from 8,500,000 units at $0.08 to 11,500,000 [...]

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES INCREASE TO NON-BROKERED PRIVATE PLACEMENT 2018-03-08T09:07:26+00:00

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES CLOSING OF FIRST TRANCHE OF AN OVER-SUBSCRIBED NON-BROKERED PRIVATE PLACEMENT

2018-03-08T09:08:18+00:00

Vancouver, British Columbia / March 5, 2018 – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) is pleased to announce that, due to high demand, it has closed the first tranche of its over-subscribed private placement (the “Private Placement”) raising gross proceeds of $824,000 by the issuance of 10,300,000 units (the [...]

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES CLOSING OF FIRST TRANCHE OF AN OVER-SUBSCRIBED NON-BROKERED PRIVATE PLACEMENT 2018-03-08T09:08:18+00:00

ADVANCED PROTEOME THERAPEUTICS AND IMMUNOBIOCHEM CORPORATION ENTER INTO A COLLABORTATION AND OPTION AGREEMENT

2018-02-17T09:31:18+00:00

Feb 7, 2018 (Vancouver, BC and Toronto, ON): Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem Corporation, today announced entering into a Collaboration and Option agreement to develop superior antibody-drug conjugates.  The companies will evaluate the prospect of combining ImmunoBiochem’s proprietary antibody and APC’s site-selective conjugation technology to produce ADCs [...]

ADVANCED PROTEOME THERAPEUTICS AND IMMUNOBIOCHEM CORPORATION ENTER INTO A COLLABORTATION AND OPTION AGREEMENT 2018-02-17T09:31:18+00:00

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES NEW PATENT GRANT

2018-02-17T09:25:10+00:00

Vancouver, British Columbia / February 5th, 2018– Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) is pleased to announce that the Japanese Patent Office has decided to grant a patent for APC’s Japanese Patent Application No. :2015-511804, titled "Site specific Labeling and Targeted Delivery of Proteins for the Treatment of Cancer". [...]

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES NEW PATENT GRANT 2018-02-17T09:25:10+00:00

ADVANCED PROTEOME THERAPEUTICS EXPANDS ANTIBODY-DRUG CONJUGATE COLLABORATION

2017-12-06T11:38:32+00:00

  Vancouver, British Columbia / November 20, 2017 – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) a biotechnology company focused on developing superior targeted protein therapeutics, is expanding the collaboration with the National Research Council of Canada (NRC) and receiving support from its Industrial Research Assistance Program (NRC IRAP) to [...]

ADVANCED PROTEOME THERAPEUTICS EXPANDS ANTIBODY-DRUG CONJUGATE COLLABORATION 2017-12-06T11:38:32+00:00

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES 2017 AGM RESULTS AND CORPORATE UPDATE

2017-08-03T19:22:56+00:00

VANCOUVER, BC--(Marketwired - July 31, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) a biotechnology company focused on developing superior targeted protein therapeutics, today announced the election of its board of directors from its Annual General Meeting (the "AGM") of shareholders, held on Wednesday July 26, 2017. Shareholders [...]

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES 2017 AGM RESULTS AND CORPORATE UPDATE 2017-08-03T19:22:56+00:00

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES COLLABORATION TO DEVELOP CANCER THERAPEUTIC

2017-08-03T19:22:05+00:00

VANCOUVER, BC--(Marketwired - July 18, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) a biotechnology company focused on developing superior targeted protein therapeutics is pleased to announce a collaboration with the National Research Council of Canada (NRC). Through this arrangement both parties have forged a strategic relationship to [...]

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES COLLABORATION TO DEVELOP CANCER THERAPEUTIC 2017-08-03T19:22:05+00:00

ADVANCED PROTEOME THERAPEUTICS CORPORATION COMPLETED RIGHTS OFFERING FOR GROSS PROCEEDS OF APPROXIMATELY $430,000

2017-08-03T19:20:32+00:00

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 11, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE:APC)(FRANKFURT:0E8) is pleased to report that it has completed its previously announced rights offering (the "Rights Offering"). Under the Rights Offering, on July 10, 2017, 7,136,216 units of the Corporation (the "Units") were distributed at a price of $0.06 per Unit for gross [...]

ADVANCED PROTEOME THERAPEUTICS CORPORATION COMPLETED RIGHTS OFFERING FOR GROSS PROCEEDS OF APPROXIMATELY $430,000 2017-08-03T19:20:32+00:00

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES RIGHTS OFFERING

2017-08-03T19:18:41+00:00

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 1, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE:APC)(FRANKFURT:0E8) is pleased to announce that it will conduct a rights offering to raise gross proceeds of up to $1,900,281 (the "Rights Offering"). Under the Rights Offering, the Company will be offering transferable rights (the "Rights") to holders of its [...]

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES RIGHTS OFFERING 2017-08-03T19:18:41+00:00